Bibliometric and visualization analysis of indocyanine green application in hepatobiliary surgery based on Web of Science database_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

ZHENG Rujun ^1,2 , FANG Cheng ^1,2 , LI Donglun ³ , ZHOU Junan ^1,2 , LUO De ^1,2 , YANG Xiaoli ^1,2 , GAN Yu ^1,2 ,  SU Song ^1,2 ,  LI Bo ^1,2

1. Department of General Surgery (Hepatobiliary Surgery), The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, P. R. China;
2. Academician (Expert) Workstation of Sichuan Province, Luzhou, Sichuan 646000, P. R. China;
3. Duisburg Essen University Hospital Kidney Department (Essen, Germany);

Corresponding author：

SU Song, Email: 13882778554@163.com; LI Bo, Email: liboer2002@126.com

Keywords：

indocyanine green; hepatobiliary surgery; bibliometrics; visual analysis

DOI：

10.7507/1007-9424.202410120

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To understand the authors, countries/regions, institutions, journals and hot topics about the application research of indocyanine green (ICG) in hepatobiliary surgery. Methods This study conducted a bibliometric analysis of the literatures on the application of ICG in hepatobiliary surgery in the Web of Science Core Collection from 2008 to 2024. CiteSpace software was used to evaluate and visualize collaborative networks and hot topics. Results A total of 2 267 literatures were included in this study, with a citation frequency of 50 463 times. The literatures from Japan accounted for the highest proportion, and most of the papers (13.50%) were published by Kokudo N. In China, Tian Jie had published the largest number of papers (33 articles). The research hotspots focused on liver resection, bile duct surgery, liver transplantation, and tumors, with recent hotspots including “liver preservation” and “rejection” frequently appearing. Conclusion This study aims to present the overall state and trend of the application research of ICG in hepatobiliary surgery through data capture and induction, and providing valuable references for clinicians and researchers.

Citation： ZHENG Rujun, FANG Cheng, LI Donglun, ZHOU Junan, LUO De, YANG Xiaoli, GAN Yu, SU Song, LI Bo. Bibliometric and visualization analysis of indocyanine green application in hepatobiliary surgery based on Web of Science database. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2024, 31(12): 1440-1449. doi: 10.7507/1007-9424.202410120 Copy

1.	Matos KT, Arantes T, Souza AW, et al. Retinal angiography and colour Doppler of retrobulbar vessels in Takayasu arteritis. Can J Ophthalmol, 2014, 49(1): 80-86.
2.	Koyanagi K, Ozawa S, Ninomiya Y, et al. Indocyanine green fluorescence imaging for evaluating blood flow in the reconstructed conduit after esophageal cancer surgery. Surg Today, 2022, 52(3): 369-376.
3.	Watanabe J, Takemasa I, Kotake M, et al. Blood perfusion assessment by indocyanine green fluorescence imaging for minimally invasive rectal cancer surgery (EssentiAL trial): A randomized clinical trial. Ann Surg, 2023, 278(4): e688-e694. doi: 10.1097/SLA.0000000000005907.
4.	Gan YX, Yang ZL, Pan YX, et al. Change of indocyanine green clearance ability and liver function after transcatheter intra-arterial therapies and its impact on outcomes of resectable hepatocellular carcinoma: a retrospective cohort study. Int J Surg, 2024, 110(5): 2832-2844.
5.	Lwin TM, Hoffman RM, Bouvet M. Fluorescence-guided hepatobiliary surgery with long and short wavelength fluorophores. Hepatobiliary Surg Nutr, 2020, 9(5): 615-639.
6.	Preziosi A, Cirelli C, Waterhouse D, et al. State of the art medical devices for fluorescence-guided surgery (FGS): technical review and future developments. Surg Endosc, 2024, 38(11): 6227-6236.
7.	黄徐建, 李敬东. 碘化油-吲哚菁绿乳剂在肝切除术中导航中的应用. 中国普外基础与临床杂志, 2023, 30(6): 646-649.
8.	杨勇, 李姗姗, 张正国, 等. 实时吲哚菁绿荧光成像导航技术在直肠癌手术中的应用. 中国普外基础与临床杂志, 2024, 31(1): 45-49.
9.	Moeini A, Sia D, Bardeesy N, et al. Molecular pathogenesis and targeted therapies for intrahepatic cholangiocarcinoma. Clin Cancer Res, 2016, 22(2): 291-300.
10.	Sirica AE, Gores GJ, Groopman JD, et al. Intrahepatic cholangiocarcinoma: continuing challenges and translational advances. Hepatology, 2019, 69(4): 1803-1815.
11.	Anwanwan D, Singh SK, Singh S, et al. Challenges in liver cancer and possible treatment approaches. Biochim Biophys Acta Rev Cancer, 2020, 1873(1): 188314. doi: 10.1016/j.bbcan.2019.188314.
12.	Kam AE, Masood A, Shroff RT. Current and emerging therapies for advanced biliary tract cancers. Lancet Gastroenterol Hepatol, 2021, 6(11): 956-969.
13.	Donne R, Lujambio A. The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma. Hepatology, 2023, 77(5): 1773-1796.
14.	Goyal L, Meric-Bernstam F, Hollebecque A, et al. Futibatinib for FGFR2-rearranged intrahepatic cholangiocarcinoma. N Engl J Med, 2023, 388(3): 228-239.
15.	Moris D, Palta M, Kim C, et al. Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians. CA Cancer J Clin, 2023, 73(2): 198-222.
16.	Fan W, Zhu B, Chen S, et al. Survival in patients with recurrent intermediate-stage hepatocellular carcinoma: Sorafenib plus TACE vs TACE alone randomized clinical trial. JAMA Oncol, 2024, 10(8): 1047-1054.
17.	Gunasekaran G, Bekki Y, Lourdusamy V, et al. Surgical treatments of hepatobiliary cancers. Hepatology, 2021, 73 Suppl 1: 128-136.
18.	Bahra M, Yahyazadeh A. Surgical strategies for combined hepatocellular-cholangiocarcinoma (cHCC-CC). Cancers (Basel), 2023, 15(3): 774. doi: 10.3390/cancers15030774.
19.	Wang K, Liu Y, Hao M, et al. Clinical outcomes of parenchymal-sparing versus anatomic resection for colorectal liver metastases: a systematic review and meta-analysis. World J Surg Oncol, 2023, 21(1): 241. doi: 10.1186/s12957-023-03127-1.
20.	Jiao S, Li G, Zhang D, et al. Anatomic versus non-anatomic resection for hepatocellular carcinoma, do we have an answer? A meta-analysis. Int J Surg. 2020, 80: 243-255.
21.	Dili A, Bertrand C. Laparoscopic ultrasonography as an alternative to intraoperative cholangiography during laparoscopic cholecystectomy. World J Gastroenterol, 2017, 23(29): 5438-5450.
22.	Benson RC, Kues HA. Fluorescence properties of indocyanine green as related to angiography. Phys Med Biol, 1978, 23(1): 159-163.
23.	Desmettre T, Devoisselle JM, Mordon S. Fluorescence properties and metabolic features of indocyanine green (ICG) as related to angiography. Surv Ophthalmol, 2000, 45(1): 15-27.
24.	Aoki T, Yasuda D, Shimizu Y, et al. Image-guided liver mapping using fluorescence navigation system with indocyanine green for anatomical hepatic resection. World J Surg, 2008, 32(8): 1763-1767.
25.	Nanashima A, Yano K, Tobinaga S. Efficacy of hepatic segmental visualization using indocyanine green photodynamic eye imaging. World J Surg, 2019, 43(5): 1308-1312.
26.	Urade T, Sawa H, Iwatani Y, et al. Laparoscopic anatomical liver resection using indocyanine green fluorescence imaging. Asian J Surg, 2020, 43(1): 362-368.
27.	Zheng K, He D, Liao A, et al. Laparoscopic segmentectomy Ⅳ using hepatic round ligament approach combined with fluorescent negative staining method. Ann Surg Oncol, 2022, 29(5): 2980-2981.
28.	Zhang Y, Zhang Y, Zhu J, et al. Clinical application of indocyanine green fluorescence imaging in laparoscopic lymph node dissection for intrahepatic cholangiocarcinoma: A pilot study (with video). Surgery, 2022, 171(6): 1589-1595.
29.	Achterberg FB, Bijlstra OD, Slooter MD, et al. ICG-fluorescence imaging for margin assessment during minimally invasive colorectal liver metastasis resection. JAMA Netw Open, 2024, 7(4): e246548. doi: 10.1001/jamanetworkopen.2024.6548.
30.	Ambe PC, Plambeck J, Fernandez-Jesberg V, et al. The role of indocyanine green fluoroscopy for intraoperative bile duct visualization during laparoscopic cholecystectomy: an observational cohort study in 70 patients. Patient Saf Surg, 2019, 13: 2. doi: 10.1186/s13037-019-0182-8.
31.	方程, 王飘, 苏松, 等. 吲哚菁绿荧光成像在再次胆道探查术中的对照研究. 中国普外基础与临床杂志, 2022, 29(6): 711-715.
32.	Lau NS, Ly M, Liu K, et al. Current and potential applications for indocyanine green in liver transplantation. Transplantation, 2022, 106(7): 1339-1350.
33.	Caimano M, Bianco G, Coppola A, et al. Indocyanine green clearance tests to assess liver transplantation outcomes: a systematic review. Int J Surg, 2024, 110(1): 431-440.
34.	Taylor DR, Venable GT, Jones GM, et al. Five-year institutional bibliometric profiles for 103 US neurosurgical residency programs. J Neurosurg, 2015, 123(3): 547-560.
35.	Roldan-Valadez E, Salazar-Ruiz SY, Ibarra-Contreras R, et al. Current concepts on bibliometrics: a brief review about impact factor, Eigenfactor score, CiteScore, SCImago Journal Rank, Source-Normalised Impact per Paper, H-index, and alternative metrics. Ir J Med Sci, 2019, 188(3): 939-951.
36.	Zhang J, Luo Z, Zhang R, et al. The transition of surgical simulation training and its learning curve: a bibliometric analysis from 2000 to 2023. Int J Surg, 2024, 110(6): 3326-3337.
37.	Garfield E. 100 citation classics from the Journal of the American Medical Association. JAMA, 1987, 257(1): 52-59.
38.	Chen C. Searching for intellectual turning points: progressive knowledge domain visualization. Proc Natl Acad Sci U S A, 2004, 101 Suppl 1(Suppl 1): 5303-5310.
39.	Ha GL, Lehrer EJ, Wang M, et al. Sex Differences in academic productivity across academic ranks and specialties in academic medicine: A systematic review and meta-analysis. JAMA Netw Open, 2021, 4(6): e2112404. doi: 10.1001/jamanetworkopen.2021.12404.
40.	Ishizawa T, Fukushima N, Shibahara J, et al. Real-time identification of liver cancers by using indocyanine green fluorescent imaging. Cancer, 2009, 15(11): 2491-2504.
41.	Hu Z, Fang C, Li B, et al. First-in-human liver-tumour surgery guided by multispectral fluorescence imaging in the visible and near-infrared-I/II windows. Nat Biomed Eng, 2020, 4(3): 259-271.
42.	Ishizawa T, Bandai Y, Ijichi M, et al. Fluorescent cholangiography illuminating the biliary tree during laparoscopic cholecystectomy. Br J Surg, 2010, 97(9): 1369-1377.
43.	Kawaguchi Y, Ishizawa T, Miyata Y, et al. Portal uptake function in veno-occlusive regions evaluated by real-time fluorescent imaging using indocyanine green. J Hepatol, 2013, 58(2): 247-253.
44.	Dip F, LoMenzo E, Sarotto L, et al. Randomized trial of near-infrared incisionless fluorescent cholangiography. Ann Surg, 2019, 270(6): 992-999.
45.	Takao M, Kawaguchi Y, Matsumura M, et al. Probe-based confocal laser endomicroscopy for real-time evaluation of colorectal liver metastasis in resected surgical specimens. Hum Cell, 2023, 36(6): 2066-2073.
46.	Wang X, Teh CSC, Ishizawa T, et al. Consensus guidelines for the use of fluorescence imaging in hepatobiliary surgery. Ann Surg, 2021, 274(1): 97-106.
47.	Nishino H, Hatano E, Seo S, et al. Real-time navigation for liver surgery using projection mapping with indocyanine green fluorescence: Development of the novel medical imaging projection system. Ann Surg, 2018, 267(6): 1134-1140.
48.	Ishizawa T, Masuda K, Urano Y, et al. Mechanistic background and clinical applications of indocyanine green fluorescence imaging of hepatocellular carcinoma. Ann Surg Oncol, 2014, 21(2): 440-448.
49.	Dousse D, Vibert E, Nicolas Q, et al. Indocyanine green fluorescence imaging to predict graft survival after orthotopic liver transplantation: a pilot study. Liver Transpl, 2020, 26(10): 1263-1274.
50.	Figueroa R, Golse N, Alvarez FA, et al. Indocyanine green fluorescence imaging to evaluate graft perfusion during liver transplantation. HPB (Oxford), 2019, 21(4): 387-392.
51.	Meijer RPJ, de Valk KS, Deken MM, et al. Intraoperative detection of colorectal and pancreatic liver metastases using SGM-101, a fluorescent antibody targeting CEA. Eur J Surg Oncol, 2021, 47(3 Pt B): 667-673.
52.	Dip F, Lo Menzo E, White KP, et al. Does near-infrared fluorescent cholangiography with indocyanine green reduce bile duct injuries and conversions to open surgery during laparoscopic or robotic cholecystectomy?—A meta-analysis. Surgery, 2021, 169(4): 859-867.
53.	Salehi O, Kazakova V, Vega EA, et al. Indocyanine green staining for intraoperative perfusion assessment. Minerva Surg, 2021, 76(3): 220-228.
54.	Shan L, Chen H, Yang L, et al. Near-infrared fluorescence imaging with indocyanine green for assessment of donor livers in a rat model of ischemia-reperfusion. BMC Gastroenterol, 2022, 22(1): 27. doi: 10.1186/s12876-022-02103-5.

1. Matos KT, Arantes T, Souza AW, et al. Retinal angiography and colour Doppler of retrobulbar vessels in Takayasu arteritis. Can J Ophthalmol, 2014, 49(1): 80-86.
2. Koyanagi K, Ozawa S, Ninomiya Y, et al. Indocyanine green fluorescence imaging for evaluating blood flow in the reconstructed conduit after esophageal cancer surgery. Surg Today, 2022, 52(3): 369-376.
3. Watanabe J, Takemasa I, Kotake M, et al. Blood perfusion assessment by indocyanine green fluorescence imaging for minimally invasive rectal cancer surgery (EssentiAL trial): A randomized clinical trial. Ann Surg, 2023, 278(4): e688-e694. doi: 10.1097/SLA.0000000000005907.
4. Gan YX, Yang ZL, Pan YX, et al. Change of indocyanine green clearance ability and liver function after transcatheter intra-arterial therapies and its impact on outcomes of resectable hepatocellular carcinoma: a retrospective cohort study. Int J Surg, 2024, 110(5): 2832-2844.
5. Lwin TM, Hoffman RM, Bouvet M. Fluorescence-guided hepatobiliary surgery with long and short wavelength fluorophores. Hepatobiliary Surg Nutr, 2020, 9(5): 615-639.
6. Preziosi A, Cirelli C, Waterhouse D, et al. State of the art medical devices for fluorescence-guided surgery (FGS): technical review and future developments. Surg Endosc, 2024, 38(11): 6227-6236.
7. 黄徐建, 李敬东. 碘化油-吲哚菁绿乳剂在肝切除术中导航中的应用. 中国普外基础与临床杂志, 2023, 30(6): 646-649.
8. 杨勇, 李姗姗, 张正国, 等. 实时吲哚菁绿荧光成像导航技术在直肠癌手术中的应用. 中国普外基础与临床杂志, 2024, 31(1): 45-49.
9. Moeini A, Sia D, Bardeesy N, et al. Molecular pathogenesis and targeted therapies for intrahepatic cholangiocarcinoma. Clin Cancer Res, 2016, 22(2): 291-300.
10. Sirica AE, Gores GJ, Groopman JD, et al. Intrahepatic cholangiocarcinoma: continuing challenges and translational advances. Hepatology, 2019, 69(4): 1803-1815.
11. Anwanwan D, Singh SK, Singh S, et al. Challenges in liver cancer and possible treatment approaches. Biochim Biophys Acta Rev Cancer, 2020, 1873(1): 188314. doi: 10.1016/j.bbcan.2019.188314.
12. Kam AE, Masood A, Shroff RT. Current and emerging therapies for advanced biliary tract cancers. Lancet Gastroenterol Hepatol, 2021, 6(11): 956-969.
13. Donne R, Lujambio A. The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma. Hepatology, 2023, 77(5): 1773-1796.
14. Goyal L, Meric-Bernstam F, Hollebecque A, et al. Futibatinib for FGFR2-rearranged intrahepatic cholangiocarcinoma. N Engl J Med, 2023, 388(3): 228-239.
15. Moris D, Palta M, Kim C, et al. Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians. CA Cancer J Clin, 2023, 73(2): 198-222.
16. Fan W, Zhu B, Chen S, et al. Survival in patients with recurrent intermediate-stage hepatocellular carcinoma: Sorafenib plus TACE vs TACE alone randomized clinical trial. JAMA Oncol, 2024, 10(8): 1047-1054.
17. Gunasekaran G, Bekki Y, Lourdusamy V, et al. Surgical treatments of hepatobiliary cancers. Hepatology, 2021, 73 Suppl 1: 128-136.
18. Bahra M, Yahyazadeh A. Surgical strategies for combined hepatocellular-cholangiocarcinoma (cHCC-CC). Cancers (Basel), 2023, 15(3): 774. doi: 10.3390/cancers15030774.
19. Wang K, Liu Y, Hao M, et al. Clinical outcomes of parenchymal-sparing versus anatomic resection for colorectal liver metastases: a systematic review and meta-analysis. World J Surg Oncol, 2023, 21(1): 241. doi: 10.1186/s12957-023-03127-1.
20. Jiao S, Li G, Zhang D, et al. Anatomic versus non-anatomic resection for hepatocellular carcinoma, do we have an answer? A meta-analysis. Int J Surg. 2020, 80: 243-255.
21. Dili A, Bertrand C. Laparoscopic ultrasonography as an alternative to intraoperative cholangiography during laparoscopic cholecystectomy. World J Gastroenterol, 2017, 23(29): 5438-5450.
22. Benson RC, Kues HA. Fluorescence properties of indocyanine green as related to angiography. Phys Med Biol, 1978, 23(1): 159-163.
23. Desmettre T, Devoisselle JM, Mordon S. Fluorescence properties and metabolic features of indocyanine green (ICG) as related to angiography. Surv Ophthalmol, 2000, 45(1): 15-27.
24. Aoki T, Yasuda D, Shimizu Y, et al. Image-guided liver mapping using fluorescence navigation system with indocyanine green for anatomical hepatic resection. World J Surg, 2008, 32(8): 1763-1767.
25. Nanashima A, Yano K, Tobinaga S. Efficacy of hepatic segmental visualization using indocyanine green photodynamic eye imaging. World J Surg, 2019, 43(5): 1308-1312.
26. Urade T, Sawa H, Iwatani Y, et al. Laparoscopic anatomical liver resection using indocyanine green fluorescence imaging. Asian J Surg, 2020, 43(1): 362-368.
27. Zheng K, He D, Liao A, et al. Laparoscopic segmentectomy Ⅳ using hepatic round ligament approach combined with fluorescent negative staining method. Ann Surg Oncol, 2022, 29(5): 2980-2981.
28. Zhang Y, Zhang Y, Zhu J, et al. Clinical application of indocyanine green fluorescence imaging in laparoscopic lymph node dissection for intrahepatic cholangiocarcinoma: A pilot study (with video). Surgery, 2022, 171(6): 1589-1595.
29. Achterberg FB, Bijlstra OD, Slooter MD, et al. ICG-fluorescence imaging for margin assessment during minimally invasive colorectal liver metastasis resection. JAMA Netw Open, 2024, 7(4): e246548. doi: 10.1001/jamanetworkopen.2024.6548.
30. Ambe PC, Plambeck J, Fernandez-Jesberg V, et al. The role of indocyanine green fluoroscopy for intraoperative bile duct visualization during laparoscopic cholecystectomy: an observational cohort study in 70 patients. Patient Saf Surg, 2019, 13: 2. doi: 10.1186/s13037-019-0182-8.
31. 方程, 王飘, 苏松, 等. 吲哚菁绿荧光成像在再次胆道探查术中的对照研究. 中国普外基础与临床杂志, 2022, 29(6): 711-715.
32. Lau NS, Ly M, Liu K, et al. Current and potential applications for indocyanine green in liver transplantation. Transplantation, 2022, 106(7): 1339-1350.
33. Caimano M, Bianco G, Coppola A, et al. Indocyanine green clearance tests to assess liver transplantation outcomes: a systematic review. Int J Surg, 2024, 110(1): 431-440.
34. Taylor DR, Venable GT, Jones GM, et al. Five-year institutional bibliometric profiles for 103 US neurosurgical residency programs. J Neurosurg, 2015, 123(3): 547-560.
35. Roldan-Valadez E, Salazar-Ruiz SY, Ibarra-Contreras R, et al. Current concepts on bibliometrics: a brief review about impact factor, Eigenfactor score, CiteScore, SCImago Journal Rank, Source-Normalised Impact per Paper, H-index, and alternative metrics. Ir J Med Sci, 2019, 188(3): 939-951.
36. Zhang J, Luo Z, Zhang R, et al. The transition of surgical simulation training and its learning curve: a bibliometric analysis from 2000 to 2023. Int J Surg, 2024, 110(6): 3326-3337.
37. Garfield E. 100 citation classics from the Journal of the American Medical Association. JAMA, 1987, 257(1): 52-59.
38. Chen C. Searching for intellectual turning points: progressive knowledge domain visualization. Proc Natl Acad Sci U S A, 2004, 101 Suppl 1(Suppl 1): 5303-5310.
39. Ha GL, Lehrer EJ, Wang M, et al. Sex Differences in academic productivity across academic ranks and specialties in academic medicine: A systematic review and meta-analysis. JAMA Netw Open, 2021, 4(6): e2112404. doi: 10.1001/jamanetworkopen.2021.12404.
40. Ishizawa T, Fukushima N, Shibahara J, et al. Real-time identification of liver cancers by using indocyanine green fluorescent imaging. Cancer, 2009, 15(11): 2491-2504.
41. Hu Z, Fang C, Li B, et al. First-in-human liver-tumour surgery guided by multispectral fluorescence imaging in the visible and near-infrared-I/II windows. Nat Biomed Eng, 2020, 4(3): 259-271.
42. Ishizawa T, Bandai Y, Ijichi M, et al. Fluorescent cholangiography illuminating the biliary tree during laparoscopic cholecystectomy. Br J Surg, 2010, 97(9): 1369-1377.
43. Kawaguchi Y, Ishizawa T, Miyata Y, et al. Portal uptake function in veno-occlusive regions evaluated by real-time fluorescent imaging using indocyanine green. J Hepatol, 2013, 58(2): 247-253.
44. Dip F, LoMenzo E, Sarotto L, et al. Randomized trial of near-infrared incisionless fluorescent cholangiography. Ann Surg, 2019, 270(6): 992-999.
45. Takao M, Kawaguchi Y, Matsumura M, et al. Probe-based confocal laser endomicroscopy for real-time evaluation of colorectal liver metastasis in resected surgical specimens. Hum Cell, 2023, 36(6): 2066-2073.
46. Wang X, Teh CSC, Ishizawa T, et al. Consensus guidelines for the use of fluorescence imaging in hepatobiliary surgery. Ann Surg, 2021, 274(1): 97-106.
47. Nishino H, Hatano E, Seo S, et al. Real-time navigation for liver surgery using projection mapping with indocyanine green fluorescence: Development of the novel medical imaging projection system. Ann Surg, 2018, 267(6): 1134-1140.
48. Ishizawa T, Masuda K, Urano Y, et al. Mechanistic background and clinical applications of indocyanine green fluorescence imaging of hepatocellular carcinoma. Ann Surg Oncol, 2014, 21(2): 440-448.
49. Dousse D, Vibert E, Nicolas Q, et al. Indocyanine green fluorescence imaging to predict graft survival after orthotopic liver transplantation: a pilot study. Liver Transpl, 2020, 26(10): 1263-1274.
50. Figueroa R, Golse N, Alvarez FA, et al. Indocyanine green fluorescence imaging to evaluate graft perfusion during liver transplantation. HPB (Oxford), 2019, 21(4): 387-392.
51. Meijer RPJ, de Valk KS, Deken MM, et al. Intraoperative detection of colorectal and pancreatic liver metastases using SGM-101, a fluorescent antibody targeting CEA. Eur J Surg Oncol, 2021, 47(3 Pt B): 667-673.
52. Dip F, Lo Menzo E, White KP, et al. Does near-infrared fluorescent cholangiography with indocyanine green reduce bile duct injuries and conversions to open surgery during laparoscopic or robotic cholecystectomy?—A meta-analysis. Surgery, 2021, 169(4): 859-867.
53. Salehi O, Kazakova V, Vega EA, et al. Indocyanine green staining for intraoperative perfusion assessment. Minerva Surg, 2021, 76(3): 220-228.
54. Shan L, Chen H, Yang L, et al. Near-infrared fluorescence imaging with indocyanine green for assessment of donor livers in a rat model of ischemia-reperfusion. BMC Gastroenterol, 2022, 22(1): 27. doi: 10.1186/s12876-022-02103-5.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Bibliometric and visualization analysis of indocyanine green application in hepatobiliary surgery based on Web of Science database

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content